Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
597 studies found for:    "Homologous wasting disease"
Show Display Options
Rank Status Study
1 Unknown  Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
Condition: Graft Versus Host Disease
Interventions: Biological: daclizumab;   Drug: methylprednisolone
2 Completed Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
Condition: Graft Versus Host Disease
Interventions: Drug: cyclosporine;   Drug: hydroxychloroquine;   Drug: prednisone;   Drug: tacrolimus
3 Completed Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract
Condition: Graft Versus Host Disease
Intervention: Drug: beclomethasone dipropionate
4 Not yet recruiting A Study of Obinutuzumab for Prevention of Chronic Graft-vs.-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation
Condition: Graft vs. Host Disease
Interventions: Drug: Obinutuzumab;   Drug: Placebo
5 Recruiting Phase II Trial of Natalizumab (Tysabri®) Plus Prednisone for Initial Therapy of Acute Graft Versus Host Disease (aGVHD) of the Gastrointestinal Tract
Condition: Graft Versus Host Disease
Interventions: Drug: Natalizumab;   Drug: Methylprednisolone
6 Completed Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease
Condition: Graft Versus Host Disease
Interventions: Drug: beclomethasone dipropionate;   Drug: methylprednisolone;   Drug: prednisone
7 Active, not recruiting
Has Results
Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
Condition: Graft vs. Host Disease
Interventions: Drug: Ustekinumab;   Drug: Placebo;   Drug: Tacrolimus (TAC);   Drug: Sirolimus
8 Completed Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT
Condition: Graft-Versus-Host Disease
Intervention: Drug: Cyclosporine
9 Terminated A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)
Condition: Graft Versus Host Disease
Intervention: Drug: Rituximab
10 Completed Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease
Condition: Graft Vs Host Disease
Intervention: Drug: ABX-CBL
11 Completed Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease
Condition: Graft-versus-Host Disease
Interventions: Drug: Methoxsalen;   Procedure: Extracorporeal Photopheresis
12 Recruiting A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory Chronic Graft-versus-Host-Disease
Condition: Chronic Graft-versus-host-disease
Interventions: Procedure: Extracorporeal Photopheresis (ECP);   Drug: Interleukin-2
13 Terminated
Has Results
A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients
Condition: Graft vs Host Disease
Interventions: Drug: ASEDs;   Drug: Saline
14 Completed Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease
Condition: Graft-versus-Host Disease
Interventions: Drug: Methoxsalen;   Procedure: Extracorporeal Photopheresis
15 Recruiting A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease
Condition: Graft vs Host Disease
Intervention: Biological: Donor regulatory T cell adoptive immunotherapy in chronic graft versus host disease
16 Terminated Alefacept for Prevention of Graft Versus Host Disease (GVHD)
Condition: Graft Versus Host Disease
Interventions: Drug: Alefacept (AMEVIVE®);   Drug: control group
17 Recruiting A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)
Condition: Chronic Graft Versus Host Disease
Intervention: Drug: Abatacept
18 Recruiting Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease
Condition: Graft -Versus-host-disease
Intervention: Biological: Mesenchymal stromal cells
19 Completed
Has Results
Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)
Condition: Chronic Graft-versus-host Disease
Intervention: Drug: Rituximab
20 Completed The Natural History of Graft-Versus-Host Disease in the Eyes
Condition: Graft-Versus-Host Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.